Multi-center evaluation of the fully automated PCR-based Idylla™ KRAS mutation assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer
<p>Since the advent of monoclonal antibodies against epidermal growth factor receptor (EGFR) in colorectal cancer therapy, the determination of RAS mutational status is needed for therapeutic decision-making. Most prevalent in colorectal cancer are <em>KRAS</em> exon 2 mutations (4...
Автори: | Solassol, J, Vendrell, J, Märkl, B, Haas, C, Bellosillo, B, Montagut, C, Smith, M, O'Sullivan, B, D'Haene, N, Le Mercier, M, Grauslund, M, Melchior, L, Burt, E, Cotter, F, Stieber, D, Schmitt, F, Motta, V, Lauricella, C, Colling, R, Soilleux, E, Fassan, M, Mescoli, C, Collin, C, Pagès, J, Sillekens, P |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Public Library of Science
2016
|
Схожі ресурси
Схожі ресурси
-
Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
за авторством: Jérôme Solassol, та інші
Опубліковано: (2016-01-01) -
Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
за авторством: Turpin A, та інші
Опубліковано: (2019-09-01) -
KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature
за авторством: Sarah Bouri, та інші
Опубліковано: (2020-01-01) -
KRAS mutations and endometriosis burden of disease
за авторством: Natasha L Orr, та інші
Опубліковано: (2023-07-01) -
Clinical Significance of the KRAS Mutation
за авторством: Sead Beganovic
Опубліковано: (2010-10-01)